Health Condition 1: null- Breast Cancer
Conditions
Interventions
Intervention1: MAK: MAK 4
MAK 5
Intervention2: MAK (MAK 4 and MAK 5): MAK 4 paste dose 2tsf twice a day with milk orally.
MAK 5 dose 2tablets twice a day with luke warm water orally for a period of 5
Sponsors
Maharishi Ayurveda Products Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients who are willing to participate in the study. 2. Women between age18 and 70 years, with histopathologically confirmed breast carcinoma of maximum diameter equal to 2.1 cm or above in whom neoadjuvant chemotherapy is planned. 3.Patients with skin involvement with fixed nodal metastasis will also be included. 4.Patients signed written informed consent. 5.Patients with normal liver and renal function test and normal ECG and echocardiogram.
Exclusion criteria
Exclusion criteria: 1. Patients unwilling to participate. 2. Pregnant and lactating women. 3. Patients with concomitant severe heart, liver or renal diseases. 4. Patients with type one diabetes or uncontrolled type two diabetes with complications and/or on Insulin. 5.Patients deemed unfit to received chemotherapy due to poor general health
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete regression of tumor (clinical and pathological) in patients with breast cancer during neo-adjuvant chemotherapy.Timepoint: Clinical regression at each chemotherapy cycle (3 weekly) intervals. Pathological regression after surgery (app 6 months). | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of chemo toxicity in patients with breast cancer.Timepoint: After each chemotherapy cycle | — |
Countries
India
Contacts
Public ContactDr Anurag Srivastava
All India Institute of Medical Sciences New Delhi INDIA
Outcome results
None listed